Gentuity, GE Healthcare Collaborate to Expand Availability of Intravascular Imaging Products

Feb. 25, 2026 — Gentuity LLC, a medical technology company specializing in next-generation intravascular imaging devices, has announced a commercial collaboration with GE HealthCare to further improve the availability of Gentuity's HF-OCT Imaging System and Vis-Rx PRIME Micro-Imaging Catheter. As part of the collaboration, GE HealthCare will help expand Gentuity's reach by connecting cardiac catheterization lab customers in the United States with Gentuity products. Together, Gentuity and GE HealthCare share a goal of advancing patient care by providing tools — including the High-Frequency OCT Imaging System (HF-OCT) — designed to enable more precise planning and treatment for percutaneous coronary interventions (PCIs).

This collaboration with GE HealthCare complements Gentuity's growing direct sales and clinical support footprint in the U.S., and also strengthens joint development efforts between the two companies.

"The relationship with GE HealthCare represents an important opportunity to bring the benefits of HF-OCT intravascular imaging to a wider set of physicians and patients in the U.S." said Desmond Adler, President of Gentuity. "Together, we are enabling broader access to technologies designed to enhance clinical decision-making and optimize patient outcomes today."

"We are excited to announce Gentuity's innovative imaging technology together with our intelligent, connected cath lab solutions to support more precise PCI planning," said Jyoti Gera, CEO, CardioVascular and Interventional Solutions at GE HealthCare. "This new agreement builds on our strong existing relationship and will help bring enhanced intraprocedural visualization to more clinicians, with the goal of giving them greater confidence in managing complex cases and improving patient outcomes in the U.S."

Gentuity and GE HealthCare recently appeared together at the Transcatheter Cardiovascular Therapeutics Conference, one of the world's largest educational meetings dedicated to interventional cardiovascular medicine, where Gentuity's HF-OCT imaging technology was featured alongside GE HealthCare's portfolio of interventional solutions, highlighting the potential for integrated imaging modalities and workflow optimization in the cath lab. Gentuity and GE HealthCare also plan to exhibit their products together at the upcoming Cardiovascular Research Technologies Conference, held from March 7 to March 10, 2026.

For more information about Gentuity's products, please visit www.gentuity.com